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This study compared and contrasted the screening and prevention methods and strategies 
utilized by public health departments in southeastern Kentucky for both cervical and prostate 
cancer. Special attention was paid to how such efforts have influenced decreases in mortality 
rates over the past two decades. The study used both geospatial methods, such as Exploratory 
Spatial Data Analysis (ESDA) and spatial autocorrelation, and qualitative methods in form of 
interviews. The interview data showed that Kentucky public health departments had strong 
cervical cancer screening and prevention programs, but did not focus on prostate cancer 
prevention. Successes in cervical cancer screening included the expansion of resources and 
services through the Breast and Cervical Cancer Treatment Program, community outreach, and 
an increase in transportation access. For prostate cancer, only two health departments had 
reported offering any type of services. Other counties attributed prostate prevention success to an 
increase in physicians in the area and the work of employers to encourage screenings. When 
these results were explored through further geospatial data analysis, there did not seem to be any 
major correlations between the interview data and clusters of incidence and mortality rate 
changes. The reasons for a decrease in mortality in cervical cancer are more evident than for 
prostate cancer, from the perspective of the health department. The key finding was that prostate 
cancer does not garner the public funding support that cervical cancer does. In order to discover 
the cause for prostate cancer mortality rate decrease in southeastern Kentucky, the public health 
department is not the ideal place to look.  
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High poverty and unemployment rates, lack of health insurance, low median family 
income, and low population density have all been shown to correlate with high cancer mortality 
rates, especially in how those factors relate to education, health literacy and access in areas such 
as the Appalachian United States (Appalachian Regional Commission 2008). In 1999 the 
Kentucky Cancer Program, the Kentucky Department for Public Health, and the American 
Cancer Society developed an action plan with funding from the Centers for Disease Control and 
Prevention to tackle and address these issues. Cancer can occur in various anatomical sites, each 
with a unique etiology, set of risk factors, and demographic target, such as age and gender. 
Prevention of each type of cancer must be approached in such a way that addresses those 
differences. For example, cervical and prostate cancers both affect the reproductive system but 
clearly involve different genders, causation, and recommended screening methods. Goal six of 
the CDC’s action plan specifically aims to reduce cervical cancer mortality in Kentucky women 
through early detection and increased screening. Goal eight addresses the informed decisions of 
Kentucky men regarding the risks and benefits of prostate cancer screening (KCC 2012). 
Nationally, both cancers have high survival rates when detected in their early stages. This 
supports the assertion that early detection is a crucial component of efforts to decrease mortality 
rates (NIH 2012). For cervical cancer, pap smears have proven to be an effective and safe 
screening method. With the discovery of its infectious causation, cervical cancer prevention 
strategies have developed even further with the recent creation and marketing of the Human 
Papilloma Virus (HPV) vaccine. Screening methods for prostate cancer have also been 
developed, including the prostate-specific antigen (PSA) test. However, the true causation of 
prostate cancer is still unknown and, in recent years, the PSA test has come under scrutiny. This 
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reality results in differences in cancer prevention campaign strategies and limitations in the 
amount of funding allocated for such campaigns. 
According to the Kentucky Cancer Registry, cervical and prostate cancer mortality rates 
have decreased significantly in southeastern Kentucky over the past twenty years (KCR 2012). 
Cervical cancer reduction in southeastern Kentucky has been a well-documented phenomenon 
with many preventative strategies implemented by local health departments. How has prostate 
cancer been addressed at the population-level in southeastern Kentucky, if at all, and how does it 
differ from the way cervical cancer has been addressed? Does prostate cancer require a different 
form of intervention than cervical cancer? How might population-level strategies be improved to 
further reduce both cancers in the region? This study examines the screening and prevention 
approaches of cervical and prostate cancer from the perspective of local public health 
departments in southeastern Kentucky through the integration of geospatial and qualitative 
methods. The aim of the study is to compare the way the two cancers are handled at the 




SIGNIFICANCE OF RESEARCH  
Rationale and Justification 
 According to the American Cancer Society, prostate cancer is the second-leading cause 
of cancer mortality in U.S. men, accounting for 9.7% of all cancer deaths.  In contrast, cervical 
cancer accounts for 1.5% of all cancer deaths of U.S. women (American Cancer Society 2013). 
Both are worth examining and researching in order to further reduce the effects of cancer on the 
U.S. population. Historically, higher overall cancer mortality has been associated with the state 
of Kentucky and, even more so, the Appalachian counties (Appalachian Regional Commission 
2008). However, whereas Kentucky has one of the highest cervical cancer death rates in the 
nation, along with several other states in the southeastern United States, the prostate cancer death 
rate is only slightly above average (CDC 2012). As a result, certain cancers, such as lung, breast, 
cervical, and colorectal have received more attention from publically funded health agencies and 
initiatives than cancers of other sites (KCC 2012).  As scientists work to discover the complex 
etiologies of various site-specific cancers, cancer screening and prevention programs and 
services are designed and offered based on the scientific evidence and funding support available. 
It is very important to analyze cancer trends and potential reasons for success of preventive 
measures so methods can be improved and shared in order to minimize excess death. 
Personal Motives 
 In an effort to better understand how to evaluate changes in disease trends and how 
successes in screening and prevention outreach may relate to those changes, a comparison of 
prostate and cervical cancer prevention strategies was proposed for this project. Because 
Appalachian Kentucky is a region of great personal interest, the initial exploratory spatial data 




The Importance and Impact of Cancer Screening and Prevention 
 According to the National Cancer Institute, cancer screening refers to medical tests 
designed to find cancer at an early stage prior to any symptoms. This is critical because for most 
cancers, noticeable symptoms are an indication that the cancer has grown and spread. At later 
stages, cancers are often much more difficult to treat and cure. Screenings can involve physical 
exams and history taking, laboratory tests, imaging procedures, and even genetic tests in search 
of a gene mutation. Screening methods can be subject to potential harms and false results and do 
not necessarily guarantee increased longevity. Depending on the type and site of the cancer in 
question, the success of screening can vary (NCI 2012). Screenings are not used to diagnose 
cancer, but they can provide information regarding the next steps towards a diagnosis. An 
abnormal screening result can lead to the decision to perform a more invasive biopsy. The U.S. 
Preventative Services Task Force (USPSTF) has the responsibility of creating centralized 
recommendations about the frequency and target demographics of various screening methods 
(USPSTF 2012). These recommendations often directly influence health policy, fund allocation, 
and public medical opinions. 
 Through the use of clinical trials and various epidemiological studies, the effectiveness 
and safety of cancer screenings can be determined. If a test is found to be accurate and confident, 
then it becomes a standard test, like pap smears have become for cervical cancer (NCI 2012). 
Signs that a screening method is of use can be determined by looking at increased early-stage 
diagnosis incidence rates and decreased age-adjusted mortality rates. The Surveillance, 
Epidemiology, and End Results (SEER) program of the National Cancer Institute aims to collect 
data on survival rates to see if early detection truly affects longevity. These studies try to account 
for misleading trends due to over-diagnosis and “lead-time bias,” or the appearance of an 
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increase in survival time simply because the test led to an earlier diagnosis. The SEER data 
regarding the cancers of interest in this study, cervical and prostate, show that the earlier stage of 
detection leads to a greater chance of recovery (Tables 1 and 2). Relative survival is a measure of 
the cancer patient survival in comparison to the general population in order to account for the 
effect of the cancer. 
Table 1: Cervical Cancer 5-year Relative Survival by Stage at Diagnosis for 2002-2008, All 
Races, Female 
 
Stage at Diagnosis 5-year Relative Survival (%) 
Localized (confined to primary site) 90.7 
Regional (spread to regional lymph nodes) 56.7 
Distant (cancer has metastasized) 16.2 
(SEER 2012) 
Table 2: Prostate Cancer 5-year Relative Survival by Stage at Diagnosis for  
2002-2008, All Races, Male 
 
Stage at Diagnosis 5-year Relative Survival (%) 
Localized (confined to primary site) 100.0 
Regional (spread to regional lymph nodes) 100.0 
Distant (cancer has metastasized) 27.8 
(SEER 2012) 
 Relative survival is high when the cancer is diagnosed earlier at more localized sites. 
Screening methods can help attain an early diagnosis. Such tests often come with a medical bill 
attached, so there have been many publicly-funded efforts to make these services available to 
those at high risk who don’t have the ability to pay for such services. Another very important 
strategy in the fight against cancer is prevention. Cancer prevention can include counseling 
people to alter their diet, engage in physical activity, avoid risk behaviors such as smoking, and 






Cervical cancer occurs at the cervix uteri, which connects the uterus to the vagina. It is 
primarily caused by a sexually transmitted infectious agent known as the Human Papilloma 
Virus (HPV). Approximately 70% of cervical cancer cases have been linked to the types 16 and 
18 of the virus (Roden and Wu 2006). HPV has also been associated with other gynecological 
cancers of the vulva and vagina. Several exacerbating risk factors include smoking, positive HIV 
status, the prolonged use of birth control pills, and giving birth to multiple children. In its early 
stages, cervical cancer may not cause overt symptoms, but in later stages symptoms include 
abnormal vaginal bleeding or discharge. Screening before these symptoms occur is crucial to the 
prevention of cervical cancer. An abnormal test result of cancerous cells will prompt treatment. 
Depending on the severity, treatment may consist of chemotherapy, radiation therapy, or surgical 
removal of tissue (CDC 2012). 
The Pap smear, the standard screening test used for the early detection of cervical cancer, 
is a collection of cervical cells and mucous which is sent to a laboratory to look for precancerous 
cells. It is often performed in conjunction with a physical pelvic exam. The same sample can also 
be checked for HPV to see if the patient has been infected (CDC 2012). As of March 2012, the 
Preventive Services Task Force recommendation for the Pap smear is “screening for cervical 
cancer in women ages 21 to 65 years with cytology (Pap smear) every 3 years or, for women 
ages 30 to 65 years who want to lengthen the screening interval, screening with a combination of 
cytology and human papillomavirus (HPV) testing every 5 years (USPSTF 2012).”  
The discovery of the role of HPV in the etiology of cervical cancer has prompted the 
development and widespread distribution of the HPV vaccine. Currently, there are two vaccines 
available, Cervarix and Gardasil. The vaccine is administered over 6 months in 3 consecutive 
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doses. The recommended age for the vaccine is 11 to 12, in order to give the immune system 
time to develop a response prior to sexual activity.  The vaccine is available to both boys and 
girls, since males can harbor the virus and spread it sexually to others. The development of the 
vaccine has increased the scope of the target age demographic for cervical cancer prevention and 
has become an important part of the strategies of public health departments. 
At one time, cervical cancer was the leading cause of cancer death of women in the 
United States. According to the CDC databases, this has been reduced significantly in the last 40 
years due to the wide spread use of the Pap smear screening method. Joinpoint analyses of 
cancer trends can be used to evaluate changes in mortality over a period of time by using criteria 
to determine when and how frequently mortality rates have changed. The results are given as 
ranges in calendar years and the annual percent change (APC) in the mortality rates over each 
period. The joinpoint trend of cervical cancer mortality from 1975 to 2009 indicates a continued 
decline in rates (Table 3).  
Table 3: The Joinpoint Trend in U.S. Cervical Cancer Mortality with Associated  
Annual Percent Change (%) between 1975-2009, All Races, Female 
 
Trend Period 
-4.3 1975 - 1982 
-1.6 1982 - 1996 
-3.8 1996 - 2003 
-0.9 2003 - 2009 
(SEER 2012) 
Prostate Cancer 
 Prostate cancer occurs at the prostate, which is a reproductive gland that produces 
alkaline fluid for the semen. It is located below the bladder, surrounding the urethra. With age, 
the prostate can increase in size and often causes problems with urination in older men. 
Symptoms of prostate cancer are usually associated with pain or the presence of blood during 
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urination or ejaculation. The primary cause of prostate cancer is still unknown, but the disease is 
correlated with older age, family/genetic history, and race. For men at high risk, smoking 
cessation, healthier diet, and increased exercise are often considered to have a protective function 
against developing the cancer. Prostate cancer diagnosis is confirmed via biopsy or transrectal 
ultrasound. Depending on the severity of the cancer, treatment can include radiation therapy, 
hormonal therapy, or complete surgical removal of the prostate (CDC 2012). 
There are two screenings used for detecting prostate cancer. One is known as a digital 
rectal exam (DRE) which consists of palpation inside the rectum to feel for an enlarged prostate 
or any lumps or abnormalities. The second is the prostate-specific antigen (PSA) blood test 
which measures the amount of PSA. A high PSA level is indicative of a prostate problem, but the 
level can also be high due to an infection, age, race, and medications, and does not necessarily 
mean the patient has prostate cancer (CDC 2012). The current cancer screening recommendation 
for prostate cancer includes a digital rectal exam (DRE) for men over age 50. Due to high 
variability in PSA test results and misdiagnosis of asymptomatic prostate conditions, in May 
2012 the USPSTF recommended against PSA-based screening (USPSTF 2012). In practice, the 
PSA test continues to be ordered by many medical practitioners for men at average risk after age 
50 and for men at unusually high risk because of family history or other factors after age 40. 
Before the use of this test, it is very important that the patient undergoes an informed decision-
making process sifting through the benefits, risks, and uncertainties. False positives can cause 
unnecessary anxieties. Subsequent diagnostic biopsies may lead to complications (Smith 2011).  
 In the United States, prostate cancer is the second leading cause of cancer death in men. 
The PSA test received FDA approval in 1986 as a monitor for treatment response and disease 
recurrence, and in 1994, as a screening tool for diagnosis (RPCI 2010). The joinpoint trend of 
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prostate cancer mortality from 1975 to 2009 indicates that rates began to decrease after the 1991-
1994 time period which points to the beneficial effects of the PSA test (Table 4). 
Table 4: The Joinpoint Trend in U.S. Prostate Cancer Mortality with Associated  
Annual Percent Change (%) between 1975-2009, All Races, Male 
 
Trend Period 
0.9 1975 - 1987 
3.1 1987 - 1991 
-0.7 1991 - 1994 
-3.9 1994 - 2004 
-3.2 2004 - 2009 
(SEER 2012) 
Cancer in Southeastern Kentucky 
 Cancer is the second-leading cause of death in the state of Kentucky, surpassed only by 
cardiovascular disease (KYCHFS 2010). Lung, colorectal, breast, and prostate are the four most 
common causes of cancer-related death in the state (KCR 2012). By comparing the age-adjusted 
mortality rates for cancer between the U.S., the state of Kentucky, non-Appalachian Kentucky 
and Appalachian Kentucky, we can draw conclusions about how the Appalachian parts of 
Kentucky are doing in relation to the rest of the country (Table 5). For all cancer sites and 
cervical cancer, there is a difference between non-Appalachian and Appalachian areas. For 
prostate cancer, the rate of the Appalachian region seems rather consistent with the non-
Appalachian region and the rest of the country. In fact, the mortality rate is slightly higher for 
non-Appalachian KY.  
Table 5: Comparison of Age-Adjusted Mortality Rates per 100,000 between 2005-2009 
 
Cancer Site U.S. Kentucky Non-Appalachian KY Appalachian KY
All Sites 178.7 208.6 201.8 224.8 
Cervical 2.4 2.9 2.6 3.5 
Prostate 23.6 24.3 24.3 24.1 
(SEER 2012 and KCR 2012) 
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 A study based in Ohio explored the differences in mortality rates between Appalachian 
and non-Appalachian regions for various types of cancers, including cervical and prostate. The 
study discovered that cervical cancer mortality rates were much higher in Appalachian counties, 
but mortality rates were actually lower for prostate. Of all the cancers studied, cervical cancer 
appeared to be most associated with disparities in healthcare access and risk behaviors. Evidence 
from the Youth Risk Behavior Surveillance System suggested that earlier sexual intercourse of 
Appalachian girls linked to the infectious causation of cervical cancer may play a role in these 
differences (Fischer 2008). Although we can’t directly apply these findings to the situation in the 
state of Kentucky, it certainly gives us something to think about with regards to the urgency of a 
disparity-related cancer like cervical in Appalachian counties versus prostate cancer which 
doesn’t seem to be correlated with disparity.  
Barriers to Screening and Prevention 
 One of the greatest barriers to cancer screening and prevention is the inability to pay for 
screening and subsequent treatment if needed. In 1990, the U.S. congress passed the Breast and 
Cervical Cancer Mortality Prevention Act which enabled the creation of the CDC’s National 
Breast and Cervical Cancer Early Detection Program. The program’s objectives were to provide 
uninsured and underserved women in the United States access to breast and cervical screening 
services, including mammograms, Pap smears, HPV tests, diagnostic testing for abnormal 
results, and treatment referrals. In 2000, Congress passed the Breast and Cervical Cancer 
Prevention and Treatment Act in order to further extend funding for treatment, too. Under this 
new legislation, women could participate in the Breast and Cervical Cancer Treatment Program 
(BCCTP) and obtain access to a Medicaid medical card to pay for services. These programs have 
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eligibility requirements; for example, the patient must be a certain age and must be at or below 
250% of the federal poverty level (CDC 2012). 
 Prostate cancer has not received the legislative support that cervical cancer has, and 
health workers in various communities still confront many challenges. According to some 
findings, men often have greater difficulty participating in preventive services than women do. A 
study on the health perspectives of Appalachian women showed that women often play the roles 
of “gatekeepers” to the health of their families. They are much more likely to communicate with 
doctors about their own health concerns and are more likely to participate in annual preventative 
exams (Schoenberg et al. 2008). Men, on the other hand, are more likely to forgo things like 
cancer screenings. One interesting qualitative study looked at the barriers to and sources of 
influence for prostate cancer screening among rural men. The study found that most men in the 
study feared that prostate screening would be too embarrassing, painful, and long (Oliver et al. 
2011). 
 Despite these known barriers to cancer screening and prevention, southeastern Kentucky 
counties seem to have found a way to overcome some of these challenges, as indicated by the 
decreases in mortality rates for both prostate and cervical cancers. This study seeks to examine 
what has been done during the past twenty years and what is currently being done to address 





Type of Study 
 This study used both geospatial and qualitative methods to examine changes in cervical 
and prostate cancer mortality in 21 counties in southeastern Kentucky between two time periods 
1995-1999 and 2005-2009. The result is a presentation of geospatial results and discussion of the 
qualitative themes and patterns that resonate throughout the Big Sandy, Cumberland Valley, and 
Kentucky River districts regarding potential differences in the implementation of cancer 
screening and prevention programs for cervical and prostate cancers. Studies with cancer 
mortality have limitations based on the fact that cancer often has long latency periods and has 
multi-factorial causations and risk factors. The study did not aim to specifically associate a 
particular program or strategy with decrease in mortality rates, only to search and identify 
potential explanations for why cervical and prostate cancer efforts seem to have been so 
successful in a region that has historically suffered from healthcare disparities. 
Exploratory Spatial Data Analysis (ESDA) 
 In order to get a general idea of cancer mortality trends in the region of interest, 
Appalachian Kentucky, exploratory spatial data analysis (ESDA) was performed. Using the 
online Kentucky Cancer Registry (KCR 2012) interactive mapping tool, county-level incidence 
and mortality rates for cancers of the breast, cervix uteri, prostate, and colon were recorded 
(Figures 1, 2, 3, and 4). For each cancer, rates were mapped for the time periods of 1995-1999 
and 2005-2009, respectively. All four cancers listed above were chosen for initial analysis 
because the state of Kentucky is actively working to address each according to the CDC’s action 




Figure 1: KCR Generated Map of Cervical Cancer Mortality by County, 2005-2009 
 
 







Figure 3: KCR Generated Map of Female Breast Cancer Mortality by County, 2005-2009 
 
Figure 4: KCR Generated Map of Colorectal Cancer Mortality by County, 2005-2009 
 
After initial visualization for the entire state, the incidence and mortality rates for the 54 counties 
classified under the Appalachian Regional Commission (2008) were downloaded from the 
Kentucky Cancer Registry website for all four cancers of interest, and maps of percent change 
were produced using ArcGIS software (Figures 5 and 6). 
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Figure 5: ArcGIS Mapping of Percent Change in Incidence Rates for Kentucky Cancers,  































Figure 6: ArcGIS Mapping of Percent Change in Mortality Rates for Kentucky Cancers,  





































By looking at the percent change between 1995-1999 and 2005-2009, the cancers with the 
highest regional increase or decrease in mortality and incidence could be determined. Through 
the ESDA, cancer mortality trends were visualized, which helped in the selection of which 
counties and which cancers to explore. Prostate and cervical cancer appeared to have the clearest 
mortality decrease and were chosen for further analysis. 
 Location of Study 
Based on the information gathered during the ESDA, 21 Appalachian Kentucky counties 
that comprise the area development districts (ADDs) of Big Sandy, Kentucky River and 
Cumberland Valley were selected (Table 6).  These are shown in Figure 7. ADDs are regions of 
the state that are headed by councils who oversee various planning issues and services.  
Table 6: List of Kentucky Counties in Area Development Districts in Study Area 
  
Big Sandy Kentucky River Cumberland Valley 
Floyd, Johnson, Magoffin, 
Martin, Pike 
 
Breathitt, Knott, Lee, Leslie, 
Letcher, Owsley, Perry, Wolf 
 
Bell, Clay, Harlan, Jackson, 
Knox, Laurel, Rockcastle, 
Whitely 
 
Figure 7: Kentucky Council of Area Development Districts in Study Area 
 (KCADD 2009) 
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This region showed improved cervical and prostate cancer outcomes over the two time periods, 
1995-1999 and 2005-2009. Table 7 shows percent changes in mortality rates between the two 
time intervals for the three area development districts (Table 7).  The decline in cervical and 
prostate cancer mortality was found to be consistent across all three ADDs in a preliminary data 
analysis of mortality rates published by the KCR (2012). 
Table 7: Percent Change in Mortality for Selected Area Development Districts 
  
Percent Change in Age-Adjusted Mortality Rates in Appalachian Kentucky 
(1995 -1999 to 2005 -2009) 
Area Development District Cervical Cancer Prostate 
Big Sandy -66.90% -15.28% 
Cumberland Valley -28.55% -29.67% 
Kentucky River -21.36% -27.47% 
(KCR 2012) 
Data-Gathering Procedures 
 Cancer mortality statistics and online interactive mapping applications provided by the 
Kentucky Cancer Registry (KCR 2012) were used to geographically confirm that the three-ADD 
study area has seen a decline in cervical and prostate cancer mortality from 1995 to 2009.  
Qualitative data collection in the form of semi-structured interviews served as a means of 
investigating the possible reasons for the cancer mortality trends of cervical and prostate cancer 
in the study area. The interviews were conducted with directors and representatives of Kentucky 
public health departments. The questions were mostly open-ended and incorporated topics such 
as which cancer screening and prevention strategies were in place, if and how they made an 
impact, which links exist between the program and the observed impact, and the perceived 
barriers to decreasing cancer mortality rates (see Appendix I: Interview Questions). There are 21 
counties located in the ADDs of the Big Sandy, Cumberland Valley, and Kentucky River, but 
some counties have merged into district health departments. The Cumberland Valley District 
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incorporates the counties of Clay, Harlan, Jackson, and Rockcastle. The Kentucky River District 
Health Department incorporates the counties of Knott, Lee, Leslie, Letcher, Owsley, Perry, and 
Wolf. The remaining 10 counties are overseen by independent county health departments. 
Interviews were conducted with all 12 departments in the region of interest. 
Data-Analysis Procedures 
 The interview questions were written in a semi-structured format in order to allow the 
interviewee to expand on various topics of concern. The responses to all questions were analyzed 
and categorized into various themes. Topics that were addressed by one interviewee were not 
necessarily addressed by others. The interview structure allowed for this type of variation in 
order to gather the most information possible regarding the individual communities and how the 
health department representative viewed the issues within his or her own community. The extent 
that prostate cancer was addressed was measured by determining whether or not a health 
department provided prostate cancer screening services and whether or not they could comment 
on services that were offered in the community by other entities. This was juxtaposed against the 
extent to which cervical cancer screening services were offered by the same health department.  
An iterative process was utilized. Once qualitative data were collected and analyzed, the 
research returned to geospatial methods in order to determine how interview responses 
corresponded to individual-county and district mortality rates. Statistical methods included 
analysis of variance (ANOVA) of incidence and mortality rates of prostate cancer between 
counties that offered no prostate screening services, counties that did not offer services through 
the department but noted effective outside services, and counties with departments that did offer 
prostate screening services. The objective was to see if there was more variation within these 
groupings or between groupings to see if the presence of services correlated with greater 
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decreases in mortality rates. Next, a geospatial method known as the local index of spatial 
autocorrelation (LISA) was used to evaluate the possible existence of spatial clusters of cancer 
rates in the region of study, specifically whether or not certain counties had higher or lower rates 
than would normally be expected due to chance.  For the LISA method, the free software, GeoDa 
(GeoDa 2013) was used. In addition, attention was returned to incidence rate data for both 
prostate and cervical cancer to see how information extracted from the qualitative interviews 






 The interviews produced a variety of themes and information in regards to how cervical 
and prostate cancers are dealt with in southeastern Kentucky communities by the public health 
departments. It was clear that all public health departments provided standard services for 
cervical cancer screening and prevention. When asked about prostate cancer screening and 
prevention, very few interviewees provided knowledge of services offered directly by the 
department. Some interviewees mentioned other prostate cancer screening efforts outside of the 
public health department that seem to have been effective in recent years (Table 8). The 
information extracted from the interviews showed that prostate cancer screening and prevention 
was not a common initiative of county and district level health departments. 
Table 8: Presence of Southeastern Kentucky Health Department Services for Prostate and 
Cervical Cancer Screenings, 2013, Based on Study Interviews 
 
Health Department Cervical Cancer 
Services Provided by 
Department? 
Prostate Cancer 




Provided by Others? 
Bell County Yes No No






Floyd County Yes Yes No
Johnson Yes No No
Kentucky River 
District (Knott, Lee, 
Leslie, Letcher, 
Owsley, Perry, Wolf) 
Yes  No  Yes 
Knox Yes No No
Laurel Yes No Yes
Magoffin Yes No No
Martin Yes No No
Pike Yes Yes No




Cervical Cancer Services 
All public health departments confirmed that there were strong programs in place for 
cervical cancer screening and prevention. One of the most important transitions over the past two 
decades has been the extension of funding from just screening to diagnostic treatment. The 
Whitely County Health Department stated that before this transition, women would take part in 
the free screenings, but if cancerous cells were discovered, they were expected to seek out 
treatment on their own even if they were without insurance (personal communication, Gail 
Timperio, Whitely County Health Department, 2/11/2013). Ten out of the 12 health departments 
mentioned the success of the BCCTP funding since the year 2000, which has enabled uninsured 
or underinsured women to have access to a Kentucky Medicaid medical card for treatment of 
breast and cervical cancers. The Cancer Program Director of the Breathitt County Health 
Department expressed frustration with the limitations on how funds are spent in this program. 
The funding is only for cervical and breast cancers, and if a woman is diagnosed with vaginal 
cancer and not cervical cancer, that medical card is no longer available to her (personal 
communication, Penny Mauk, Breathitt County Health Department, 2/11/2013). Nonetheless, 
this extension of funding was viewed as one of the major improvements in the region for cervical 
cancer. 
Another trend that has been taking place is an increase in outreach funding and other 
community partnerships for southeastern Kentucky women. The Kentucky River District Health 
Department has been able to receive additional funding from the state for social-based activities 
like “Ladies Day” where women come for free health information and services and, in return for 
attending, are given gift cards for local businesses (personal communication, Sharon Dunaway, 
Kentucky River District Health Department, 2/4/2013). In Johnson County, a partnership with 
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the University of Kentucky Extension Office was established in recent years. The health 
department has been invited to participate in the “Homemakers Program” meetings by providing 
information sessions and other women’s health promotion activities (personal communication, 
Teresa Lawson, Johnson County Health Department, 2/13/2013). Other counties, such as 
Magoffin, have found it useful to use newspapers and other forms of media to publish 
information about programs and free services (personal communication, Marlene Robertson, 
Magoffin County Health Department, 2/11/2013). 
Challenges to Cervical Cancer Screening and Prevention 
Six out of 12 interviewees listed transportation to services as a major barrier for women  
participating in cervical cancer screening services, including the Kentucky River District and the 
independent counties of Martin, Magoffin, Laurel, Johnson, and Knox. To address this challenge, 
the Kentucky River District seeks to encourage the use of the Human Service Transportation 
Delivery Program. If patients meet certain criteria, they are offered free transportation to get to 
health services (personal communication, Sharon Dunaway, Kentucky River District Health 
Department, 2/4/2013). 
Nine out of 12 interviewees still said that one of the greatest challenges was getting 
women to come in for the services, even with all of the programs available for transportation and 
helping with the cost of the tests. Representatives of Floyd and Pike County specified that in 
their communities, women may come in for the screening, but fail to return for the follow-up 
(personal communication, Thelma Lafferty, Floyd County Health Department, 2/11/2013; 
personal communication, Stephanie Whitely, Pike County Health Department, 2/11/2013). In the 
Cumberland Valley District, subsidization of services is based on income qualifications. The 
interviewee expressed the concern that because of this detail, they can’t really advertise the 
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cervical cancer services as “free,” and this tends to deter many women because they are afraid it 
will still cost them something (personal communication, Kathy Smith, Cumberland Valley 
District Health Department, 2/25/2013).  
The health department interviewees of Breathitt, Martin, and Johnson Counties all 
showed deep concern about how the recent change in the USPSTF recommendation for cervical 
cancer screening is affecting their programs. The Cancer Program director of Breathitt County 
specifically exhibited great frustration with changes in policy. “We worked so hard to convince 
these women how important annual Pap smears were. Now we have to tell them it is only 
necessary once every three years? They start to lose faith in the information we give them. They 
become confused (personal communication, Penny Mauk, Breathitt County Health Department, 
2/11/2013).” In Johnson County, when women came in for annual Pap smears, they had the 
convenience of synchronizing their breast exams and other important screenings. Now that Pap 
smears are only recommended once every three years, they assume the other exams can wait, 
too. “They won’t come in now just for breast (personal communication, Teresa Lawson, Johnson 
County Health Department, 2/13/2013).” The Program Manager of Martin County indicated she 
is curious to see if the policy change will affect mortality statistics several years down the road 
(personal communication, Penny Dye, Martin County Health Department, 2/11/2013). 
Prostate Cancer Services 
 All public health department interviewees stated that prostate cancer screening and 
prevention was not a major focus for them. Only two out of the 12 health departments 
interviewed actually provided prostate cancer screening services. Floyd County Health 
Department offers a “Men’s Health Day” once a year, which falls around Father’s Day and 
includes free PSA testing (personal communication, Thelma Lafferty, Floyd County Health 
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Department, 2/11/2013).  In Pike County, the department did receive federal funding to have an 
evening Male Clinic with a doctor who provided services for sexually-transmitted diseases 
(STDs) and PSA tests. However that funding was recently cut despite good participation 
(personal communication, Stephanie Whitely, Pike County Health Department, 2/11/2013). 
 A few interviewees mentioned successful prostate cancer screening services that were 
offered by the private sector. In the Kentucky River District, it has been observed that some 
private insurance companies associated with employers such as Wayne Supply have been 
instituting “well visits” on-site. Medical providers come to the workplace, provide health 
information, perform physicals, and offer PSA tests. In this environment, the men take part in 
health promotion and prevention with the moral support of their own peers and co-workers and, 
most importantly, do not have to miss work to go to the doctor for these services (personal 
communication, Sharon Dunaway, Kentucky River District Health Department, 2/4/2013). 
Whitely County and Laurel County Health Department representatives both claimed that one of 
the major successes in prostate cancer mortality decrease in their communities was due to the 
fact that more healthcare providers have come into the area and have been spreading awareness 
about the benefits of screening and have, as a result, ordered more PSA tests (personal 
communication, Gail Timperio, Whitely County Health Department, 2/11/2013; personal 
communication, Deborah Hackert, Laurel County Health Department, 2/11/2013). There are no 
hard data in this particular study to support this claim, however, it would be interesting in a 
future study to gather information to confirm this speculation.  
Challenges to Prostate Cancer Screening and Prevention 
 With the exception of Floyd and Pike Counties which explicitly provided PSA testing 
services, most public health departments claimed to only see men rarely and for services like 
29 
 
STD testing, flu shots, other vaccinations, home health, diabetic counseling, and work-related 
adult prevention physicals. In the Kentucky River District, when men are in for these types of 
routine services, the nurses try to use the opportunity to provide men in the target demographic 
with information about prostate cancer so that they will consider asking their doctor about 
pursuing screening (personal communication, Sharon Dunaway, Kentucky River District Health 
Department, 2/4/2013). All interviewees agreed that the reality is that funding is not available for 
prostate cancer-specific programs. “We can only do what we get funding for. I personally think 
that hepatitis is a huge problem is this community, but we can’t do much for it at the moment 
(personal communication, Teresa Lawson, Johnson County Health Department, 2/13/2013).” 
However, not all interviewees even saw prostate cancer as a pressing problem in their 
communities. For example, the clinic representative from Magoffin County Health Department 
even asserted that prostate cancer wasn’t a true problem in their community and that the 
department should be focusing more on the health issues of women instead, especially cervical 
and breast screenings (personal communication, Marlene Robertson, Magoffin County Health 
Department, 2/11/2013). Very few interviewees chose to elaborate on the issue of prostate 
cancer, primarily because the public health departments simply do not provide services for it. 
 The Whitely County Health Department interviewee felt that mixed messages regarding 
the need for and reliability of the PSA test was a major barrier for men across the region. The 
men begin to question whether or not the screening is truly necessary and become confused 
about the information they hear from others and on the news regarding changes in USPSTF 
recommendations (personal communication, Gail Timperio, Whitely County Health Department, 
2/11/2013). All departments expressed that from their observations, men in general do not seek 
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out preventative services or health providers as often as women and have a very stubborn attitude 
about their health.  
Gender Differences in General Cancer Screening Services 
 All interviewees suggested that adult men are generally less likely to seek out 
preventative services and health providers than adult women. An interesting counter-
development in Johnson County is that HPV vaccination in local school campaigns has been 
more successful with young boys than with young girls. The interviewee admitted that in the 
very conservative community, the parents of young girls are hesitant to allow their children to be 
vaccinated for fear that it will encourage early sexual activity. Although this is a small triumph 
for the participation of males in cancer prevention measures, this describes the behavior of male 
children in cancer prevention services and not male adults (personal communication, Teresa 
Lawson, Johnson County Health Department, 2/13/2013).  
In Martin County, it was confirmed that both men and women are targeted for colorectal 
cancer screenings. However, it has been more difficult to attract men than women to the services. 
It was the belief of the representative that colorectal cancer is a challenging cancer to approach, 
especially with men, because of the fear and embarrassment that is evoked by the intimate nature 
of the screening procedure (personal communication, Penny Dye, Martin County Health 
Department, 2/11/2013). In Bell County, they are having the same issue in promoting colon 
cancer screening for men. In fact, they are hardly seeing men at all for those services (personal 
communication, Jessica Mills, Bell County Health Department, 2/26/2013).  
The Problem of Apathy 
 According to the Director of the Whitely County Health Department, the greatest 
obstacle to cancer screening and prevention is no longer access to care. Instead, there is a 
troubling mindset of not wanting to be screened. In the Director’s opinion, this is a problem that 
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can be seen across almost all public health department initiatives and programs, from STDs to 
smoking cessation. People tend to assume that preventive services are unnecessary wastes of 
time and money, especially when it is difficult to observe quick and obvious results.  “Apathy is 
an overriding issue in southeastern Kentucky (personal communication, Gail Timperio, Whitely 
County Health Department, 2/11/2013).” For cervical cancer, it has been clearly shown that 
improvements in screening outreach and extension of funding for free or subsidized treatment 
options have been successful. However, for future endeavors, the apathy of southeastern 
Kentucky citizens will need to be addressed.  
Return to Geospatial Methods 
All 12 health departments confirmed that they had cervical cancer screening and 
prevention services covering all 21 counties. The Big Sandy, Cumberland Valley, and Kentucky 
River ADDs had an overall decrease in cervical cancer mortality between 1995-1999 and 2005-
2009. Going back to county-level data, however, we can see that some individual counties within 
those districts actually had increases in cervical cancer mortality. The most common barriers 
reported for those counties were transportation and lack of funding to extend services (Table 9).  
Table 9: Kentucky Counties with Increases in Cervical Cancer Mortality,  
Percent Change between 1995-1999 and 2005-2009 
 
Name of County Percent Change in 
Mortality 
Most Frequently Reported Barrier via Interviews 
Harlan* +100.26% Lack of funding to extend services 
Knox +24.33% Transportation 
Magoffin +13.46% Lack of funding to extend services; Transportation 
Wolfe* +141.01% Transportation 
* - The cervical cancer mortality rates for Harlan and Wolfe Counties were slightly unstable due 
to the small number of deaths within such small population centers (KCR 2012). 
 
Table 8 listed the extent to which prostate services were offered in each health 
department. Only two counties claimed to offer prostate cancer screening services (Floyd and 
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Pike Counties, denoted by Y/N).  Of the remaining 19 counties, nine had notable successes of 
non-health department affiliated screening services (like Laurel County, denoted by N/Y) while 
10 didn’t reference any services at all (like Bell County, denoted by N/N).  An ANOVA was 
performed to see if the reported presence of prostate cancer screening services correlated with 
greater decreases in mortality (Table 10).  
Table 10: ANOVA of Percent Change in Mortality between Health Departments with No 
Services (N/N), No Services but Addressed in Other Ways (N/Y), and Provided Services (Y/N)  
 
SUMMARY
Groups Count Sum Average Variance
N/N 10 ‐248.34 ‐24.834 2437.87
N/Y 9 ‐219.21 ‐24.3567 1234.043
Y/N 2 ‐40.57 ‐20.285 92.34405
ANOVA
Source of Variation SS df MS F P‐value F crit
Between Groups 34.89461 2 17.4473 0.009843 0.99021 3.554557
Within Groups 31905.52 18 1772.529
Total 31940.42 20  
The same was performed on incidence rates (Table 11). 
Table 11: ANOVA of Percent Change in Incidence between Health Departments with No 
Services (N/N), No Services but Addressed in Other Ways (N/Y), and Provided Services (Y/N) 
 
SUMMARY
Groups Count Sum Average Variance
N/N 10 20.54 2.054 578.1901
N/Y 9 98.79 10.97667 694.5893
Y/N 2 54.43 27.215 390.0425
ANOVA
Source of Variation SS df MS F P‐value F crit
Between Groups 1170.147 2 585.0733 0.944473 0.40733 3.554557
Within Groups 11150.47 18 619.4704
Total 12320.61 20  
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According to the p-values, which all happen to be much greater than 0.05, there was no 
correlation between reported presence of prostate cancer screening services and greater decreases 
in mortality and incidence rates. Perhaps a better analysis of prostate screening via collection of 
data from other health clinics and local urologists would be helpful in confirming a correlation in 
a future study. 
Spatial Autocorrelation 
 ArcGIS county boundary shapefiles with corresponding disease rates were used with 
GeoDa software to examine spatial autocorrelation and identify potential disease clusters. Spatial 
autocorrelation statistics are used to measure and analyze the degree of dependency among 
various observations in a geographic region. This concept is based on the understanding that 
spatial objects relate to each other and are similar and tend to cluster together (GeoDa 2013).  
One common global spatial autocorrelation statistic is the Moran’s Index; “global” meaning that 
it looks over the entire study area. Moran’s Index tests with univariate data such that a value 
between -1 and +1 indicates whether or not a data set is clustered (+1), random (0), or dispersed 
(-1). For the percent change in incidence rates, both cervical cancer and prostate cancer have a 
Moran’s Index that indicates an overall random distribution. For percent change in mortality 
rates, prostate cancer has a stronger value towards evenly dispersed, whereas cervical cancer is 
slightly clustered (Table 12). According to the p-values, the Moran’s Index based on percent 
change in prostate mortality is statistically significant. 
Table 12: Moran's Index Values for LISA Results 
 
Cancer Site Moran’s Index based on % 
Change in Incidence 
Moran’s Index based on % 
Change in Mortality 
Cervical -0.00269605 (p-value 0.234) 0.114556 (p-value 0.113) 
Prostate -0.0919593 (p-value 0.418) -0.264047 (p-value 0.031) 
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Globally, these results do not show strong clustering or dispersion, but they are consistent with 
the conclusions drawn from the qualitative data that prostate cancer improvement is rather 
dispersed and not correlated with public health department actions, while local cervical cancer 
improvement may correspond with program success.  
After considering global clustering, Local Index Spatial Autocorrelation (LISA) was used 
to see if there were any significant clusters at the local level, or within certain sections of the 
study area. The generated maps indicate the absence or presence of spatial clusters or outliers. 
The aim was to look for improvement by how much mortality had decreased over time. Areas of 
least concern are indicated in blue, having the greatest decrease in mortality rates and the most 
improvement. Areas of most concern are indicated in red, having the least improvement.  
Figure 8: LISA Map of Cervical Cancer Percent Change in Incidence Rate 
 
Figure 8 shows the percent change of incidence of cervical cancer, and shows two clusters: a 
cluster of greater decreases in Floyd and Martin Counties and smaller decrease in the counties of 
Lee, Clay, and Laurel (Figure 8). Although clustered in proximity, Lee, Clay, and Laurel 




Figure 9: LISA Map of Cervical Cancer Percent Change in Mortality Rate 
 
Figure 9 used the percent change of mortality of cervical cancer, and shows two clusters: a 
cluster of greater decreases in Floyd and Pike Counties and smaller decrease in Lee (Figure 9). 
One might consider from the cluster of Floyd and Pike counties that both noted the positive 
effect of service expansion within the past 20 years and how that has enabled many underserved 
women to get Pap smears when they would have never been able to get them otherwise. Counties 
more to the west, such as Lee, which is under the umbrella of the Kentucky River District Health 
Department with lots of support and resources, is a much larger department that may have had its 
greatest successes prior to the time frame studied. Further analyses are needed to properly 




Figure 10: LISA Map of Prostate Cancer Percent Change in Incidence Rate 
 
 For prostate cancer data, Figure 10 showed the percent change of incidence, which 
showed no patterns of clustering (Figure 10). This means the change in incidence rates of the 











Figure 11: LISA Map of Prostate Cancer Percent Change in Mortality Rate 
 
Figure 11 looked at mortality, which only showed outliers of Martin County having a greater 
decrease in mortality rates amongst adjacent counties with a smaller decrease and Lee having a 
much smaller decrease in mortality rates amongst adjacent counties with a much larger decrease 
(Figure 11). From the information gathered regarding the presence of prostate services in those 
two counties, no conclusions can really be drawn except the fact that Lee County having 
reportedly effective non-department affiliated PSA-test programs did not bear at all on helping to 
decrease mortality rates relative to other counties. The same applies to Martin County in that it 
was able to have success relative to the surrounding counties without any reported presence of 
community PSA test services. 
Trends in Incidence vs. Mortality Rates 
 Finally, using the information extracted from the qualitative methods, the study returned 
to incidence rates. Mortality rates were the major focus of the study because a decrease in 
mortality rates indicates less death attributed to the disease, putatively the result of catching 
cancer in its earlier stages for more effective treatment and overall developments in better 
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treatments. Looking back to Table 7, the percent change in mortality decreased for both cervical 
and prostate cancer between the two periods 1995-1999 and 2005-2009 (Table 7). For percent 
change in incidence, however, there was a decreased incidence for cervical cancer and an 
increase in prostate cancer (Table 13).  
Table 13: Percent Change in Incidence for Selected Area Development Districts 
Percent Change in Age-Adjusted Incidence Rates in Appalachian Kentucky 
(1995 -1999 to 2005 -2009) 
Area Development District Cervical Cancer Prostate 
Big Sandy -66.53% 8.49% 
Cumberland Valley -14.17% 3.25% 
Kentucky River -42.44% 12.44% 
(KCR 2012) 
However, in the qualitative part of the study, it was clear that public health departments were 
much more dedicated in increasing access to cervical Pap smears than PSA tests. If more Pap 
smears are being performed because of an extension of public health department services and 
this leads to a decrease in mortality rates, why wouldn’t incidence be increasing as well? An 
explanation for this difference lies in the fact that abnormal cervical Pap smears often indicate 
the presence of pre-cancerous cells, which leads to fast action and successful removal of those 
cells before cancer even begins. In contrast, the PSA test only works because the presence of the 
antigen itself is a sign that something may already be wrong with the prostate, which can lead to 
a complete cancer diagnosis even in its early stages. For this reason, Pap smears are a much more 
effective preventive screening method than PSA tests and this has led to a decline in cervical 
cancer diagnoses (and, therefore, in incidence rates) because of their ability to screen for 




 The decrease in age-adjusted mortality of cervical and prostate cancers in southeastern 
Kentucky implied that efforts to provide screening and treatment have been successful for both 
cancer sites. To better understand what those efforts have been, staff members of 12 health 
department covering all 21 counties in the defined southeastern Kentucky region were 
interviewed. In this study, several reasons were proposed for cervical cancer successes. 
However, the general consensus was that prostate cancer is not a primary focus of southeastern 
Kentucky public health departments. There is little to no funding allocated for such services at 
the health department level, and the focus seems to be concentrated in the private sector, if at all.  
Effective Strategy – The Power of Groups 
Effective strategies often harness the power of group solidarity. For cervical cancer, 
events like Ladies Day where women can come together and participate in health promotion and 
prevention activities have been quite successful. For prostate cancer, “well visits’ within the 
workplace appear to provide positive social cohesion and support among co-workers to take part 
in otherwise seemingly solitary and embarrassing medical situations.  
Limitations in Department Funding 
 It was consistent from the information gathered through the interviews that the 
southeastern Kentucky public health departments had little to no funding available for prostate 
cancer screening and prevention in comparison to cervical cancer, which happened to receive a 
lot of funding and support from both state and federal levels. Funding allocation favors 
preventative measures that are well-documented and publically accepted. Until prostate cancer 
research secures a more definitive screening test and uncovers a better understanding of its 
etiology, it is unlikely that more public funding will be spent on such services. Also, because of 
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cervical cancer’s label as a disease of disparity, there is more urgency to address it in 
southeastern Kentucky. Public health departments have to prioritize their initiatives, and prostate 
cancer just doesn’t garner that type of support at this time.  
Policy Changes Often Cause Confusion 
 The Pap smear is a very effective and reliable screening method for cervical cancer. Even 
when something as solid and publically-supported as the Pap smear undergoes new USPSTF 
recommendations, confusion can ensue. It can disrupt established visit routines by patients, as 
was observed in the Johnson and Breathitt County Health Departments. For prostate cancer, the 
PSA test is now recommended against by the USPSTF. Misleading and contradicting medical 
information can spread quickly and ultimately deter men from pursuing those services. It is still 
very important for health providers to educate men about the benefits and risks involved and 
seek out other screening methods, such as the DRE. However, the lack of overall reliability for 
wide-spread use of PSA tests and a confused public adds up to an unfortunately erratic climate 
for secured public funding and established programs put forth by public health departments. 
Until better screening methods and clearer preventative measures are developed for prostate 
cancer, the potential for effective screening and prevention at the population-level does not 




The results of this small study prompt various other concerns that might be of academic 
and practical interest. One study that may be needed for us to properly understand how prostate 
cancer screening and prevention is being handled in southeastern Kentucky is to gather 
information on screening trends from the private sector, since that appears to be where prostate 
cancer screening is most extensive. In addition, now that colorectal cancer is becoming a more 
wide-spread focus of Kentucky public health departments, it would be very interesting to 
compare the differences in screening reception between southeastern Kentucky males and 
females. By looking at one screening method of one cancer that both genders experience with 
similar risk factors, we may be able to shed some light on specific barriers that men may 
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1. What is your position with the _____ County Health Department? 
2. How long have you held your position? 
3. Tell me about your educational and professional background. 
4. Have you ever worked in a public health-related position in another county? 
 
Health Department Services and Initiatives 
 
1. In ___ County, can you think of any specific changes or improvements in 
program strategies over the past 20 years that might account for the decrease in cervical 
cancer mortality? 
2. In ___ County, can you think of any specific changes or improvements in 
program strategies over the past 20 years that might account for the decrease in prostate 
cancer mortality? 
 
Successes and Barriers 
 
1. What are the most difficult challenges in cervical cancer screening and 
prevention? 
a. What has the Health Department tried to overcome those challenges? 
2. What are the most difficult challenges in prostate cancer screening and 
prevention? 
a. What has the Health Department tried to overcome those challenges?  
3. In your opinion, what is the biggest difference between addressing cervical cancer 
and prostate cancer in _____ County? 
4. Does the Department have any data regarding cancer screening behaviors for pap 
smears, PSA tests, or Digital Rectal Exams? 
5. Are there specific barriers that southeastern Kentucky males face in prostate 
cancer screening and prevention? 
a. Why is prostate cancer different from cervical cancer in this respect? 
6. (If not already addressed) How do gender/socioeconomic status/level of education 
affect cervical and prostate cancer outcomes? 
